CAITLIN O'MALLEY: Open Payments
NPI 1265100853 · ROCKLIN, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$690 in 27 payments from 9 companies in 2025. Trend: 2023 $2,395 · 2024 $1,224 · 2025 $690
Food & beverage: $602Education: $88
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $265 |
| Janssen Biotech, Inc. | 6 | $151 |
| Regeneron Healthcare Solutions, Inc. | 3 | $71 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $64 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 2 | $44 |
| Lilly USA, LLC | 2 | $43 |
| Arcutis Biotherapeutics, Inc. | 1 | $21 |
| Organon LLC | 1 | $18 |
| Janssen Pharmaceuticals, Inc | 1 | $13 |
Products named: TREMFYA, DUPIXENT, ILUMYA, RINVOQ, SKYRIZI, JUBLIA, TALTZ, HUMIRA.
Industry payments across CA — which companies pay providers there.
